Answer from top 3 papers
Cannabidiol (CBD) has shown promise as a potential treatment for panic attacks and anxiety disorders. Preclinical evidence strongly supports CBD's anxiolytic effects for various anxiety-related conditions, including panic disorder, when administered acutely (). A review of studies on CBD's anti-panic properties in both animal models and human volunteers consistently suggests an anxiolytic-like effect ().
Interestingly, while preclinical research indicates that enhancing CB1 receptor agonism may improve fear extinction, a clinical trial examining CBD as an adjunctive therapy for anxiety disorders did not find significant improvements in treatment outcomes (). This contradiction highlights the need for further research to understand the optimal dosage, timing, and specific mechanisms of CBD in treating panic attacks and anxiety disorders.
In conclusion, while CBD shows potential as a treatment for panic attacks and anxiety disorders, more clinical trials involving patients with panic disorder diagnoses are needed to clarify its specific mechanism of action and determine safe and effective therapeutic doses (). The current evidence supports CBD's anxiolytic properties, but primarily in acute dosing scenarios, emphasizing the need for studies on chronic CBD administration in relevant clinical populations ().